Debra Miller Cox, MD
Infectious Disease · Spartanburg, SCNPI 1144279860
Payments from drug & device makers
What this record shows
12 manufacturers reported payments, led by Inari Medical, Inc. at 59.0% of the total. Reporting peaked in 2024 at $824 and has fallen 71.7% since, to $233 in 2025.
Across 28 payments — averaging $49.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inari Medical, Inc.$821
- Smith+Nephew$193
- Next Science LLC$147
- AbbVie$60
- Viiv Healthcare Company$49
- Reprise Biomedical, Inc.$26
- plus $97 from 6 others
What the payments were for
- Travel & lodging$76855%
- Food & beverage$62545%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inari Medical, Inc. | 3 | $821 |
| Smith+Nephew | 10 | $193 |
| Next Science LLC | 1 | $147 |
| AbbVie | 4 | $60 |
| Viiv Healthcare Company | 3 | $49 |
| Reprise Biomedical, Inc. | 1 | $26 |
| Reapplix Inc. | 1 | $22 |
| Gilead | 1 | $21 |
| Hydrofera LLC | 1 | $19 |
| Medtronic | 1 | $16 |
| Molnlycke Health Care US, LLC | 1 | $13 |
| Advanced Oxygen Therapy Inc. | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FLOWTRIEVER CATHETER, S$768
- CT THROMBECTOMY SYSTEM KIT$768
- Xperience$147
- BlastX$147
How this compares
$1,392 in reported general payments places this provider in the 55th percentile of 102 infectious disease providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 12 | $10,803 |
| CeftriaxoneCeftriaxone Sodium | 25 | $3,508 |
| MicafunginMicafungin Sodium | 14 | $3,073 |
| Vancomycin Hcl | 27 | $2,362 |
| Fluconazole | 29 | $613 |
| Doxycycline Hyclate | 33 | $533 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 28 | $437 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 24 | $242 |
| Ciprofloxacin Hcl | 17 | $120 |
| Ondansetron Hcl | 11 | $111 |
| Gabapentin | 13 | $102 |
| Lorazepam | 12 | $25 |
Paid to pharmacies, not to this prescriber.
Other infectious disease in Spartanburg
- Stanley MillerSpartanburg$7K
- Theodore GrieshopSpartanburg$3K
- Elizabeth AbellSpartanburg$2K
- Casey CronanSpartanburg$2K
- Benjamin WhittSpartanburg$1K
- Emilie HillSpartanburg$1K
- Michelle CarneySpartanburg$646
- Timothy HenkelHilton Head Island$1.8M
- Toby FugateCharleston$136K
- John McKinnonCharleston$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.